BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20:213-227. [PMID: 24105394 DOI: 10.1097/01.mib.0000436959.62286.f9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Raymond SB, Gee MS, Anupindi SA, Shailam R, Kaplan JL, Nimkin K. CT and MRI of Rare Extraintestinal Manifestations of Inflammatory Bowel Disease in Children and Adolescents. J Pediatr Gastroenterol Nutr 2016;63:e1-9. [PMID: 27050046 DOI: 10.1097/MPG.0000000000001225] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Fradkov E, Sheehan J, Cushing K, Higgins PDR. Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin Disease. Inflamm Bowel Dis 2021:izab201. [PMID: 34591972 DOI: 10.1093/ibd/izab201] [Reference Citation Analysis]
3 Hanzel J, Ma C, Casteele NV, Khanna R, Jairath V, Feagan BG. Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease. Drugs 2021;81:333-47. [PMID: 33400241 DOI: 10.1007/s40265-020-01460-3] [Reference Citation Analysis]
4 Pagani K, Lukac D, Bhukhan A, McGee JS. Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview. Am J Clin Dermatol 2022. [PMID: 35441942 DOI: 10.1007/s40257-022-00689-w] [Reference Citation Analysis]
5 Sonoyama H, Mishima Y, Ishihara S, Oshima N, Moriyama I, Kawashima K, Chinuki Y, Morita E, Kinoshita Y. Ten-year follow-up study of linear immunoglobulin A dermatosis complicated with ulcerative colitis. Clin J Gastroenterol 2020;13:164-9. [PMID: 31555959 DOI: 10.1007/s12328-019-01047-w] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Rispo A, Musto D, Imperatore N, Testa A, Rea M, Castiglione F. Dramatic improvement of severe acne pustolosa after adalimumab in a patient with ulcerative colitis. Clin Case Rep 2016;4:348-50. [PMID: 27099725 DOI: 10.1002/ccr3.520] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD. J Can Assoc Gastroenterol 2019;2:S73-80. [PMID: 31294387 DOI: 10.1093/jcag/gwy053] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
8 Bonciolini V, Bianchi B, Del Bianco E, Verdelli A, Caproni M. Cutaneous Manifestations of Non-Celiac Gluten Sensitivity: Clinical Histological and Immunopathological Features. Nutrients 2015;7:7798-805. [PMID: 26389946 DOI: 10.3390/nu7095368] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
9 Anderson A, Ferris LK, Click B, Ramos-Rivers C, Koutroubakis IE, Hashash JG, Dunn M, Barrie A, Schwartz M, Regueiro M, Binion DG. Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients. Dig Dis Sci. 2018;63:2729-2739. [PMID: 29713987 DOI: 10.1007/s10620-018-5056-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
10 Shahid S, Myszor M, De Silva A. Pyoderma gangrenosum as a first presentation of inflammatory bowel disease. BMJ Case Rep. 2014;2014. [PMID: 25385558 DOI: 10.1136/bcr-2014-204853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
11 Teich N. Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn's disease. Tech Coloproctol 2014;18:965-6. [PMID: 24965074 DOI: 10.1007/s10151-014-1192-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
12 Luzoro A, Sabat P, Guzmán L, Frias F. Manifestaciones extraintestinales de enfermedad inflamatoria intestinal. Revista Médica Clínica Las Condes 2019;30:305-14. [DOI: 10.1016/j.rmclc.2019.06.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Walker AM, Chong BF. SnapshotDx Quiz: February 2022. Journal of Investigative Dermatology 2022;142:e15-20. [DOI: 10.1016/j.jid.2021.11.021] [Reference Citation Analysis]
14 Johns HR, Shetty N, Cash J, Patel T, Pourciau C. Bowel-Associated-Dermatosis-Arthritis Syndrome (BADAS) as early presentation of ulcerative colitis in an adolescent girl. Pediatr Dermatol 2022. [PMID: 35191547 DOI: 10.1111/pde.14954] [Reference Citation Analysis]
15 Flynn RL, Chowdhury MH, Rudolph J, Einstein S. Rare Presentation of Postsurgical Pyoderma Gangrenosum Presenting as Necrotizing Soft Tissue Infection. Adv Skin Wound Care 2019;32:507-11. [PMID: 31498172 DOI: 10.1097/01.ASW.0000579692.74662.bb] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, Paoluzi P, Vernia P. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 2014; 20(46): 17463-17467 [PMID: 25516659 DOI: 10.3748/wjg.v20.i46.17463] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
17 Iida T, Hida T, Matsuura M, Uhara H, Nakase H. Current clinical issue of skin lesions in patients with inflammatory bowel disease. Clin J Gastroenterol 2019;12:501-10. [PMID: 30838512 DOI: 10.1007/s12328-019-00958-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Shohdy KS, Rashad W, Elmeligui A. Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine. Middle East J Dig Dis 2018;10:50-4. [PMID: 29682249 DOI: 10.15171/mejdd.2017.91] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ekwunife CN, Nweke IG, Achusi IB, Ekwunife CU. Ulcerative Colitis Prone to Delayed Diagnosis in a Nigerian Population: Case Series. Ann Med Health Sci Res. 2015;5:311-313. [PMID: 26229722 DOI: 10.4103/2141-9248.160188] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Antonelli E, Bassotti G, Tramontana M, Hansel K, Stingeni L, Ardizzone S, Genovese G, Marzano AV, Maconi G. Dermatological Manifestations in Inflammatory Bowel Diseases. J Clin Med 2021;10:364. [PMID: 33477990 DOI: 10.3390/jcm10020364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
21 Yanai H, Amir Barak H, Ollech JE, Avni Biron I, Goren I, Snir Y, Banai Eran H, Broitman Y, Aharoni Golan M, Didkovsky E, Amitay-Laish I, Ollech A, Hodak E, Dotan I, Pavlovsky L. Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic. Therap Adv Gastroenterol 2021;14:17562848211053112. [PMID: 34777576 DOI: 10.1177/17562848211053112] [Reference Citation Analysis]
22 Facheris P, De Santis M, Gargiulo L, Pavia G, Valenti M, Manara S, Borroni RG, Costanzo A, Narcisi A. Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report. J Clin Immunol 2020;40:1038-40. [PMID: 32648026 DOI: 10.1007/s10875-020-00819-1] [Reference Citation Analysis]
23 Kou CX, Zhang YY, Li GW, Li J, Kong QT, Chen J, Liu F, Zhang M, Wang FY, Jiang Y, Hao LY, Ren JA, Sang H. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study. J Eur Acad Dermatol Venereol 2018;32:e211-2. [PMID: 29194792 DOI: 10.1111/jdv.14720] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Alfurayh N, Alhumidi A, Alkeraye S. Pyodermatitis vegetans responding to rifampicin and clindamycin. JAAD Case Rep 2019;5:1078-80. [PMID: 31799357 DOI: 10.1016/j.jdcr.2019.10.006] [Reference Citation Analysis]
25 Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome. Clin Exp Immunol 2014;178:48-56. [PMID: 24903614 DOI: 10.1111/cei.12394] [Cited by in Crossref: 141] [Cited by in F6Publishing: 112] [Article Influence: 17.6] [Reference Citation Analysis]
26 Uzunçakmak TK, Akdeniz N, Karadağ AS, Çobanoğlu B. Pyodermatitis vegetans after total colectomy. Indian Dermatol Online J 2015;6:S9-S11. [PMID: 26904460 DOI: 10.4103/2229-5178.171052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Rocha TB, Garate ALSV, Beraldo RF, Lanças SHS, Leite FV, Quera R, Barros JR, Baima JP, Saad-Hossne R, Sassaki LY. Leukocytoclastic Vasculitis as an Extraintestinal Manifestation of Crohn's Disease. Case Rep Gastroenterol 2021;15:825-31. [PMID: 34720830 DOI: 10.1159/000519003] [Reference Citation Analysis]
28 Yamaguchi Y, Nakagawa M, Nakagawa S, Nagao K, Inoue S, Sugiyama T, Izawa S, Hijikata Y, Ebi M, Funaki Y, Ogasawara N, Sasaki M, Kasugai K. Rapidly Progressing Aseptic Abscesses in a Patient with Ulcerative Colitis. Intern Med 2021;60:725-30. [PMID: 32999240 DOI: 10.2169/internalmedicine.5733-20] [Reference Citation Analysis]
29 Jiang YY, Li J, Li Y, Wang Q, Liu S, Fang K, Qian JM, Jin HZ. Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum. Chin Med J (Engl) 2017;130:2674-9. [PMID: 29133754 DOI: 10.4103/0366-6999.218004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Alvarez-Payares JC, Ramírez-Urrea S, Correa-Parra L, Salazar-Uribe D, Velásquez-López M. Mucocutaneous Manifestations of Inflammatory Bowel Disease. Cureus 2021;13:e17191. [PMID: 34548985 DOI: 10.7759/cureus.17191] [Reference Citation Analysis]
31 Malaty HM, Sansgiry S, Artinyan A, Hou JK. Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci 2016;61:861-4. [PMID: 26514675 DOI: 10.1007/s10620-015-3930-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]